Table 1 Description of subjects
Placebo group (n = 14) | Vitamin B6 group (n = 14) | |
|---|---|---|
Age | 57.5 (11.0) | 53.9 (12.6) |
Sex (F:M) | 9:5 | 12:2 |
Height (cm) | 168.4 (10.3) | 164.7 (9.1) |
Methotrexate (yes/all) | 7/14 | 8/14 |
Methotrexate dose (mg/week) | 7.5 (10.1) | 10.2 (11.7) |
Prednisone (yes/all) | 9/14 | 11/14 |
Prednisone dose (mg/week) | 3.1 (3.5) | 4.3 (4.0) |
NSAIDs use (yes/all) | 10/14 | 11/14 |
Duration of disease (years) | 11.6 (8.2) | 8.5 (5.6) |
Number of painful joints | 5.1 (5.1) | 7.9 (8.9) |
Number of swollen joints | 8.9 (8.7) | 8.0 (9.5) |
The Health Assessment Questionnaire disability score 1–3 scale | 1.45 (1.18) | 1.17 (0.94) |
Erythrocyte sedimentation rate | 30.2 (21.4) | 36.0 (29.9) |
Rheumatoid factor (IU/ml) | 87.2 (69.2) | 88.8 (82.9) |
Albumin (g/dl) | 3.8 (0.5) | 3.4 (0.4) |
Alkaline phosphatase (IU/l) | 76.6 (14.5) | 73.6 (23.6) |
24 h creatinine (mg/dl) | 1.02 (0.38) | 1.01 (0.42) |
C-reactive protein (mg/l) | 16.7 (16.2) | 8.6 (12.7) |